Cargando…
The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
BACKGROUND: There is wide global variance in survival from breast cancer, both in developed and developing country. However, the effect of estrogen receptor status has not been widely evaluated in Ethiopia where the incidence of breast cancer is rapidly increasing. Hence, the current study aimed to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211074/ https://www.ncbi.nlm.nih.gov/pubmed/35747466 http://dx.doi.org/10.2147/BCTT.S365295 |
_version_ | 1784730284876365824 |
---|---|
author | Belete, Abebe Muche Aynalem, Yared Asmare Gemeda, Belete Negese Demelew, Tefera Mulugeta Shiferaw, Wondimeneh Shibabaw |
author_facet | Belete, Abebe Muche Aynalem, Yared Asmare Gemeda, Belete Negese Demelew, Tefera Mulugeta Shiferaw, Wondimeneh Shibabaw |
author_sort | Belete, Abebe Muche |
collection | PubMed |
description | BACKGROUND: There is wide global variance in survival from breast cancer, both in developed and developing country. However, the effect of estrogen receptor status has not been widely evaluated in Ethiopia where the incidence of breast cancer is rapidly increasing. Hence, the current study aimed to determine the effect of estrogen receptor status on the overall survival of breast cancer patients who were treated at Black Lion Specialized Hospital, Ethiopia. METHODS: In this institution-based retrospective cohort study a total of 368 study participants were included with a one-to-one ratio of estrogen receptor negative to estrogen receptor positive. The main outcome of interest for this study was death due to breast cancer. The authors compared the women with estrogen receptor-positive and estrogen receptor-negative breast cancer for overall survival rate using log rank test. The incidence density rate of mortality was calculated for each exposed and non-exposed variable. The effect of estrogen receptor status on breast cancer mortality was estimated using the Cox proportional hazards model. RESULTS: The incidence density rate of mortality among breast cancer patients for estrogen receptor positive were found to be 5.48 (95% CI=3.94–7.64) per 1,000 person years observation; while for estrogen negative receptor status the mortality rate was found to be 10.47 (95% CI=8.19–13.37) per 1,000 person years observation. In the Cox regression analysis after ful adjustments for confounder variables, the mortality event risk was 32% higher among estrogen receptor negative (HR=1.32; 95% CI=1.08–2.91) as compared to estrogen receptor positive breast cancer patients. CONCLUSION: We have found that the incidence density rate of mortality among breast cancer patients was significantly higher in the estrogen receptor negative groups. Therefore, clinicians should give careful attention to the impact of estrogen receptor negative status on the overall outcome of clients. |
format | Online Article Text |
id | pubmed-9211074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-92110742022-06-22 The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study Belete, Abebe Muche Aynalem, Yared Asmare Gemeda, Belete Negese Demelew, Tefera Mulugeta Shiferaw, Wondimeneh Shibabaw Breast Cancer (Dove Med Press) Original Research BACKGROUND: There is wide global variance in survival from breast cancer, both in developed and developing country. However, the effect of estrogen receptor status has not been widely evaluated in Ethiopia where the incidence of breast cancer is rapidly increasing. Hence, the current study aimed to determine the effect of estrogen receptor status on the overall survival of breast cancer patients who were treated at Black Lion Specialized Hospital, Ethiopia. METHODS: In this institution-based retrospective cohort study a total of 368 study participants were included with a one-to-one ratio of estrogen receptor negative to estrogen receptor positive. The main outcome of interest for this study was death due to breast cancer. The authors compared the women with estrogen receptor-positive and estrogen receptor-negative breast cancer for overall survival rate using log rank test. The incidence density rate of mortality was calculated for each exposed and non-exposed variable. The effect of estrogen receptor status on breast cancer mortality was estimated using the Cox proportional hazards model. RESULTS: The incidence density rate of mortality among breast cancer patients for estrogen receptor positive were found to be 5.48 (95% CI=3.94–7.64) per 1,000 person years observation; while for estrogen negative receptor status the mortality rate was found to be 10.47 (95% CI=8.19–13.37) per 1,000 person years observation. In the Cox regression analysis after ful adjustments for confounder variables, the mortality event risk was 32% higher among estrogen receptor negative (HR=1.32; 95% CI=1.08–2.91) as compared to estrogen receptor positive breast cancer patients. CONCLUSION: We have found that the incidence density rate of mortality among breast cancer patients was significantly higher in the estrogen receptor negative groups. Therefore, clinicians should give careful attention to the impact of estrogen receptor negative status on the overall outcome of clients. Dove 2022-06-17 /pmc/articles/PMC9211074/ /pubmed/35747466 http://dx.doi.org/10.2147/BCTT.S365295 Text en © 2022 Belete et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Belete, Abebe Muche Aynalem, Yared Asmare Gemeda, Belete Negese Demelew, Tefera Mulugeta Shiferaw, Wondimeneh Shibabaw The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study |
title | The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study |
title_full | The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study |
title_fullStr | The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study |
title_full_unstemmed | The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study |
title_short | The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study |
title_sort | effect of estrogen receptor status on survival in breast cancer patients in ethiopia. retrospective cohort study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211074/ https://www.ncbi.nlm.nih.gov/pubmed/35747466 http://dx.doi.org/10.2147/BCTT.S365295 |
work_keys_str_mv | AT beleteabebemuche theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT aynalemyaredasmare theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT gemedabeletenegese theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT demelewteferamulugeta theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT shiferawwondimenehshibabaw theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT beleteabebemuche effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT aynalemyaredasmare effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT gemedabeletenegese effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT demelewteferamulugeta effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy AT shiferawwondimenehshibabaw effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy |